Russell Investments Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
17,804
+15,166
| +575% | +$1.58M | ﹤0.01% | 1755 |
|
|
2025
Q1 | $308K | Sell |
2,638
-16,799
| -86% | -$1.96M | ﹤0.01% | 2470 |
|
|
2024
Q4 | $1.64M | Buy |
19,437
+18,422
| +1,815% | +$1.56M | ﹤0.01% | 1765 |
|
|
2024
Q3 | $91.2K | Sell |
1,015
-819
| -45% | -$73.6K | ﹤0.01% | 2676 |
|
|
2024
Q2 | $148K | Buy |
1,834
+1,043
| +132% | +$84K | ﹤0.01% | 2546 |
|
|
2024
Q1 | $63.1K | Buy |
791
+777
| +5,550% | +$62K | ﹤0.01% | 2635 |
|
|
2023
Q4 | $1.11K | Sell |
14
-8,950
| -100% | -$712K | ﹤0.01% | 3053 |
|
|
2023
Q3 | $626K | Sell |
8,964
-15,635
| -64% | -$1.09M | ﹤0.01% | 2147 |
|
|
2023
Q2 | $1.77M | Buy |
24,599
+24,578
| +117,038% | +$1.77M | ﹤0.01% | 1633 |
|
|
2023
Q1 | $1.3K | Buy |
+21
| New | +$1.3K | ﹤0.01% | 3038 |
|
|
2021
Q4 | – | Sell |
-12,506
| Closed | -$411K | – | 2996 |
|
|
2021
Q3 | $411K | Sell |
12,506
-2,415
| -16% | -$79.4K | ﹤0.01% | 2546 |
|
|
2021
Q2 | $1.01M | Buy |
14,921
+8,045
| +117% | +$542K | ﹤0.01% | 2311 |
|
|
2021
Q1 | $388K | Buy |
6,876
+726
| +12% | +$41K | ﹤0.01% | 2620 |
|
|
2020
Q4 | $500K | Sell |
6,150
-2,049
| -25% | -$167K | ﹤0.01% | 2427 |
|
|
2020
Q3 | $583K | Sell |
8,199
-15,005
| -65% | -$1.07M | ﹤0.01% | 2321 |
|
|
2020
Q2 | $1.9M | Buy |
23,204
+21,415
| +1,197% | +$1.76M | ﹤0.01% | 1674 |
|
|
2020
Q1 | $105K | Buy |
+1,789
| New | +$105K | ﹤0.01% | 2718 |
|